Lungpacer Medical announced that it received FDA investigational device exemption (IDE) approval to begin a trial for its ...
Sooma announced that it received FDA investigational device exemption (IDE) for its transcranial direct current stimulation ...
FDA, of an Investigational Device Exemption IDE, supplement to the IDE previously announced on Jan 27, 2025, which had approved a clinical study examining the combination of Alpha DaRT and first ...
"Receiving an IDE from the FDA is a landmark achievement for Newronika," said Dr. Lorenzo Rossi, Co-Founder and CEO of Newronika. "It affirms the potential of our adaptive DBS system to fill an ...